Evaluation of CT-XPI
- Conditions
- CT ScanComputed Tomography
- Registration Number
- NCT07192133
- Lead Sponsor
- University of Wisconsin, Madison
- Brief Summary
The goal of this clinical trial is to learn if a new computed tomography (CT) lung perfusion imaging method is as effective as standard of care (SOC) CT imaging. The main question it aims to answer is:
* Does the new contrast-free method provide more information about lung perfusion than SOC?
Participants will undergo a 30 minute chest CT.
- Detailed Description
The purpose of the study is to evaluate X-ray Pulsatility Index using prospectively acquired dynamic CT, which is different from conventional static CT scans.
The primary objective of this study is to collect dynamic CT scan data with human participants using high frame rate imaging methods to produce a map of lung perfusion.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 30
- Age 18 years or older
- Able to sign and date the informed consent form
- Will undergo a clinically-indicated CT exam of the head, neck, chest, abdomen, pelvis, or extremities
- Pregnant or lactating
- In need of urgent or emergent care
- Have any conditions that, in the opinion of the PI or designee, would interfere with the evaluation of the results or constitute a health hazard for the participant
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Lung x-ray pulsatility index (XPI) 30 minutes XPI, a representative of lung perfusion, will be measured using CT images. The dynamic x-ray attenuation from each pixel is analyzed using spectral analysis.
Magnitude of XPI 30 minutes Measured as a number, this corresponds to the magnitude of the relative change of signal.
Presence of XPI 30 minutes This will be evaluated quantitatively using CNR (contrast to noise) measurements which uses a region of interest in the lungs and a region of interest outside of the lungs.
Spatial distribution of XPI signal 30 minutes This is a subjective evaluation, routinely done clinically with other modalities that measure lung perfusion. Researchers evaluate how homogenous (smooth) the signal is over the lungs and look for perfusion defects (areas with little or no XPI) which would indicate pathology.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Wisconsin - Madison
🇺🇸Madison, Wisconsin, United States
University of Wisconsin - Madison🇺🇸Madison, Wisconsin, United StatesStephanie WilsonContactSWilson8@uwhealth.orgMatthew Smith, MD, PhDPrincipal InvestigatorTimothy Szczykutowicz, PhDSub Investigator